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Specific defense mechanisms against pathogens are fulfilled by different subsets of nonmucosal conven-
tional dendritic cells (DCs), including migratory Langerhans cells (LCs), dermal DCs, and resident CD8+
and CD8 DCs found in lymphoid organs. Dermal DCs capture antigens in the skin and migrate to lymph no-
des, where they can transfer the antigens to CD8+ DCs and activate CD4+ T cells. Differential antigen-pro-
cessing machinery grants CD8+ DCs a high efficiency in activating CD8+ T cells through crosspresentation,
whereas CD8DCs preferentially trigger CD4+ T cell responses. Recent findings have revealed the important
role played by monocyte-derived DCs (mo-DCs), newly formed during infection, in activating CD4+ and CD8+
T cells, regulating immunoglobulin production, and killing pathogens. However, a number of controversial
issues regarding the function of different DC subsets during viral, bacterial, and parasitic infections remain
to be resolved.Introduction
Over the last decade, mouse experimental models of infection
have provided important insights into the identification, origin,
and functional specialization of different dendritic cell (DC) sub-
sets (reviewed by Shortman and Naik, 2007). Specific functions
related to defensemechanisms against pathogens have been at-
tributed to the main subsets of mouse conventional DCs (cDCs),
which include migratory epidermal Langerhans cells (LCs) and
dermal DCs, as well as resident CD8+ and CD8 DCs found
in peripheral lymph nodes (per-LNs) and the spleen (reviewed
by Villadangos and Schnorrer, 2007). However, these reports
have also led to controversies over the functional specialization
of different DC subsets, probably because of the fact that cur-
rently available information relies on studies that explored DC-
mediated immune responses against a limited number of patho-
gens and that were performed with widely diverse experimental
strategies. In addition, the recent finding that inflammatory
monocyte-derived DCs (mo-DCs) are formed de novo during in-
fectious processes at infection sites and lymphoid organs (re-
viewed by Leon and Ardavin, 2008b) adds an extra level of com-
plexity to the definition of specific functional capacities of DC
subsets. Here, we will discuss the current understanding of the
functional relevance of nonmucosal cDCs during in vivo immune
responses against viruses, bacteria, and parasites.
Migratory and Resident cDCs in Steady State
cDCs involved in defense mechanisms against pathogens com-
prise all the DC subsets located in antigen-capture areas related
to epithelial surfaces (such as the skin and the mucosa of the di-
gestive, respiratory, and reproductive tracts) and secondary
lymphoid organs (such as the spleen, LNs, and gut- and bron-
chial-associated lymphoid tissues). Because the role of mucosal
cDCs has been covered in recent reviews on intestinal, pulmo-
nary, and vaginal cDCs (de Heer et al., 2005; Iwasaki, 2007; Jo-
hansson and Kelsall, 2005), we will focus on the role of nonmu-
cosal cDCs in the induction of in vivo immune responses
against pathogens. Nonmucosal cDCs include those located inthe skin, per-LNs, and spleen, and they can be subdivided into
two categories: migratory cDCs and resident cDCs (reviewed
by Shortman and Naik, 2007).
Skin migratory cDCs participate in defense mechanisms
against pathogens that gain access to the epidermis or the der-
mis as a consequence of pathogen-specific skin-invasive mech-
anisms, skin lesions, or inoculation by insects, such as the ma-
laria mosquito or Leishmania sandfly. In steady state, migratory
cDCs include immature epidermal LCs and immature dermal
DCs that remain in the skin until they migrate, in the absence
of inflammation or infection, into the per-LNs through the lymph.
This migration process involves the upregulation of MHC class II
and costimulatory molecules on the surface of LCs and dermal
DCs; this implies that in steady state within the per-LNs, these
two DC subsets appear in amature state with regards to their ex-
pression of MHC class II and costimulatory molecules (reviewed
by Villadangos and Schnorrer, 2007). LCs have been demon-
strated to derive from monocytes (Ginhoux et al., 2006). Al-
though indirect evidence also supports a monocytic origin for
dermal DCs (reviewed by Leon and Ardavin, 2008b), this hypoth-
esis remains to be conclusively demonstrated. Within the per-
LNs of C57BL/6 mice, LCs and dermal DCs represent approxi-
mately 35% and 25% of total cDCs, respectively (Kamath
et al., 2002). Analyses of BrdU-labeling kinetics of LCs and der-
mal DCs within the per-LNs of C57BL/6 mice (Kamath et al.,
2002) revealed that migratory cDCs have a slow turnover (half-
life > 21 days and 12 days for LCs and dermal DCs, respectively).
Studies based on experimental models of cutaneous infection,
which use non-genetically modified mice, as well as studies
based on models that use genetically engineered mice and
that allow LC in vivo tracking or LC conditional ablation (reviewed
by Kissenpfennig and Malissen, 2006) concur on the concept
that LCs are not directly involved in the induction of pathogen-
specific T cell responses (Allan et al., 2003; Filippi et al., 2003;
Lemos et al., 2004; Zhao et al., 2003), although a role for LCs
in antigen transport to the per-LNs cannot be excluded. Never-
theless, the participation of LCs in immunity against pathogensImmunity 29, September 19, 2008 ª2008 Elsevier Inc. 343
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nig and Malissen, 2006; Villadangos and Heath, 2005), and here,
we will focus on the role of the better understood dermal DCs in
immunity against pathogens.
Immature CD8+ DCs and CD8 DCs are found in per-LNs and
the spleen. CD8+ DCs are mainly located within the T cell areas
(i.e., the per-LN paracortex and spleen inner white pulp),
whereas CD8 DCs are preferentially located in antigen-capture
areas (i.e., the per-LN subsinusal layer beneath the subcapsular
sinus, as well as the spleen marginal zone). Within the spleen of
C57BL/6 mice, CD8+ DCs and CD8 DCs represent approxi-
mately 25% and 75% of total cDCs, respectively, whereas in
the per-LNs, each subset represents approximately 20% of total
cDCs (Kamath et al., 2002). Among spleen resident cDCs, CD8+
DCs have the fastest turnover (half-life: 1.5 days), indicating that
in the steady state, they are replaced within 3 days, whereas
CD8 DCs have a lower turnover (half-life: 3 days). In contrast,
within the per-LNs, both CD8+ DCs and CD8 DCs display a lon-
ger lifespan than they do in the spleen, with a half-life of 4.5 days
for both subsets (Kamath et al., 2002). CD8 DCs can be further
subdivided into CD8CD4 and CD8CD4+ DC subsets (re-
viewed by Villadangos and Schnorrer, 2007), but because no ex-
clusive functions have been specifically ascribed to these sub-
sets regarding their role in immune responses against
pathogens, we will not refer to the subsets individually.
On the basis of current knowledge, CD8+ and CD8 DCs ap-
pear to fulfill their specific defense functions against pathogens
essentially within the environment of the per-LNs or spleen and
therefore do not appear to migrate through the blood or lymph
to other organs. However, DC-activating stimuli, such as Toll-
like receptor (TLR) ligands and inflammatory cytokines and che-
mokines, induce the maturation of resident cDCs, a process that
can determine internal migratory processes from antigen-cap-
ture areas to the T cell areas within the LNs or the spleen. Inter-
estingly, chemokine-induced migration of DCs from the splenic
marginal zone to the inner white pulp was required for bacterial
transport to the T cell areas and initiation of CD8+ T cell re-
sponses against Listeria monocytogenes (Aoshi et al., 2008 [in
this issue of Immunity]). After activation, CD8 DCs migrate
from the splenic marginal zone to the inner white pulp, where
they interact with antigen-specific T cells (De Smedt et al.,
1996). In addition, analysis of the immune response against
Toxoplasma gondii (Reis e Sousa et al., 1997) suggests that dur-
ing infection-induced inflammatory reactions, CD8+ DCsmigrate
from the outer to the inner splenic white pulp. This finding con-
trasts with the concept that in steady state, CD8+ DCs are found
in the inner white pulp T cell areas. It could therefore be hypoth-
esized that during infection, newly formed CD8+ DCs are first lo-
cated in the outer white pulp, close to the marginal zone, and
subsequentlymigrate to the T cell areas after contact with a path-
ogen. In this regard, CD8+ DCs located in the T cell areas in
steady state could be mainly involved in T cell tolerance induc-
tion (reviewed by Steinman et al., 2003). Both CD8+ DCs and
CD8 DCs appear to derive, in the steady state, from a common
nonmonocytic-precursor population (Naik et al., 2006), although
the differentiation of each subset is differentially regulated by
specific signaling pathways (reviewed by Shortman and Naik,
2007). Resident cDCs located in the per-LNs or spleen are in-
volved in immune responses against pathogens that gain access344 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.to these organs through the lymph or blood or against pathogens
transported to the per-LNs by skin migratory cDCs. The different
migratory and resident DC subsets found in steady state in the
skin, per-LNs, and spleen are summarized in Figures 1 and 2.
The phenotypic characteristics of these DC subsets are summa-
rized in Table 1.
De Novo Formation of Inflammatory DCs during
Infection
Studies performed during acute or chronic infections caused by
viruses, bacteria, and parasites have demonstrated a dramatic
increase in the number of cDCs present at both the infection
sites, such as the skin, and associated lymphoid organs, such
as the draining LNs or the spleen (Leon and Ardavin, 2008a; Mar-
tin et al., 2002; Serbina et al., 2003; Yoneyama et al., 2001). In
these locations, inflammatory cDCs are mo-DCs derived from
Ly-6C+ monocytes, which are not found in the steady state (re-
viewed by Leon and Ardavin, 2008b). Monocytes recruited to
the dermis differentiate into dermal mo-DCs, which are first lo-
cated in the dermis but subsequently migrate into the per-LNs
through the lymph. Inflammatory Ly-6C+ monocytes are re-
cruited to the skin through inflamed dermal venules by a mecha-
nism involving the interaction of P-selectin glycoprotein ligand-1
(PSGL-1) with endothelial P- and E-selectins and the interaction
of L-selectin with endothelial peripheral lymph node addressin
(PNAd; Leon and Ardavin, 2008a). Interestingly, inflammatory
dermal mo-DCs and dermal DCs found in steady state display
similar phenotypic features (Leon et al., 2007), suggesting
a monocytic origin for dermal DCs, as discussed above. Ly-
6C+monocytes recruited to the per-LNs and spleen during infec-
tion-induced inflammation differentiate into LN mo-DCs and
spleen mo-DCs, respectively. Ly-6C+ monocyte migration to
the per-LNs occurs through high endothelial venules by a mech-
anism essentially involving L-selectin and PNAd interactions
(Leon and Ardavin, 2008a). To our knowledge, no data on the
molecules involved in monocyte-endothelial interactions during
monocyte migration through the splenic marginal sinus have
been reported.
Importantly, although inflammatory DCs are considered to
correspond essentially to DCs derived from Ly-6C+ monocytes,
a strong increase in CD8+ and CD8 DC subsets has also been
reported during infection (Leon and Ardavin, 2008a; Martin et al.,
2002). These observations indicate that inflammatory cDCs also
comprise CD8+ and CD8 DCs phenotypically similar to those
found in steady state, and they suggest that inflammatory
CD8+ and CD8 DCs are formed de novo in inflammatory foci
and lymphoid organs during an infection. Several reports sup-
port the hypothesis that CD8+ and CD8 DCs formed de novo
under inflammation derive from Ly-6C+monocytes (Leon and Ar-
davin, 2008b; Leon et al., 2007; Leon et al., 2004), although this
hypothesis is still a matter of controversy and has yet to be ad-
dressed conclusively. The DC subsets found under inflammatory
conditions in the skin, per-LNs, and spleen are illustrated in
Figures 1 and 2.
Functional Relevance of Pre-existing cDCs versus
De Novo-Formed Inflammatory cDCs
Taking into account the fast turnover of per-LN and spleen cDCs
(Kamath et al., 2002), the fast increase in cDC numbers observed
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ReviewFigure 1. Conventional DC Subsets Present in the Per-LNs in Steady State and during Inflammation
In steady state, per-LN migratory cDCs comprise epidermal LCs differentiated from monocytes and dermal DCs that have also been proposed to derive from
monocytes. Both migratory cDC subsets constitutively migrate to the per-LNs and acquire a mature phenotype. Resident cDCs include CD8+ and CD8 DCs
that remain in an immature state in the absence of activating stimuli and differentiate from a common nonmonocytic precursor. During inflammatory reactions
caused by infection, pre-existing LCs and dermal DCs rapidly migrate to the per-LNs and are replaced by newly formed LCs and dermal mo-DCs derived from
inflammatory Ly-6C+ monocytes recruited to the dermis. Dermal mo-DCs are phenotypically similar to dermal DCs and also migrate to the per-LNs as mature
DCs. Whether newly formed LCs migrate to the per-LNs during infection remains to be demonstrated. Inflammatory monocytes are also recruited to the per-LNs
and differentiate into mo-DCs. Finally, resident inflammatory CD8+ and CD8 DCs are also formed during infection, but their precursors have yet to be defined.after infection (Leon and Ardavin, 2008a; Martin et al., 2002; Ser-
bina et al., 2003; Yoneyama et al., 2001), and the rapid recruit-
ment of monocytes to inflammed foci (Henderson et al., 2003;
Le Borgne et al., 2006; Palframan et al., 2001; Randolph et al.,
1999; Serbina and Pamer, 2006), we can conclude that, during
infection, migratory and resident cDCs existing before the onset
of an infectious process are rapidly replaced by newly formed
cDCs. These will include de novo-formed inflammatory mo-
DCs, as well as CD8+ and CD8 DCs. In this regard, studies ad-
dressing the role of defined cDC subsets during infection have
generally been interpreted on the basis of previous information
on migratory and resident cDCs preexisting in steady state.
This could have led to misinterpretations due to possible func-
tional differences between cDC subsets in steady state versus
inflammatory conditions, such as differences in their migration
behavior, antigen-handling capacity, and immunostimulatory
potential. Consequently, a number of conflicting points have
arisen in regards to de novo DC formation during infection. Are
steady-state dermal DCs and inflammatory dermal mo-DCs
equivalent? Are CD8+ and CD8 DCs formed during inflamma-
tion functionally equivalent to their counterparts in steady state?
Additionally, de novo formation of mo-DCs from monocytes re-
cruited to the per-LNs or spleen has not generally been takeninto consideration when the role of dermal DCs or resident
CD8- DCs during infection has been assessed. Thus, in certain
experimental infection models, a specific function that could
be fulfilled by dermal mo-DCs or LN mo-DCs could have been
ascribed erroneously to dermal DCs. Similarly, some functions
that could be carried out by dermal, LN, or spleen mo-DCs could
have been attributed incorrectly to CD8 DCs because in most
reports exploring the function of CD8 DCs during infectious
processes, CD8 DCs were characterized as CD8 CD11b+,
a definition that can also be applied to mo-DCs. These consider-
ations should be taken into account in future studies aiming to
ascertain the specific functions of defined DC subsets during in-
fectious processes.
Functional Relevance of CD8+ and CD8 DCs
in T Cell Immunity
Reports published over the last decade point to a functional di-
chotomy in the role played by CD8+ versus the role played by
CD8 DCs in the induction of immune responses against patho-
gens. On the basis of these data, CD8+ DCs were claimed to be
specialized in the induction of anti-viral CD8+ T cell responses, in
part because of their crosspriming potential, whereas CD8DCs
were proposed to be mainly involved in CD4+ T cell immunity,Immunity 29, September 19, 2008 ª2008 Elsevier Inc. 345
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ReviewFigure 2. Conventional DC Subsets Present in the Spleen in Steady State and during Inflammation
In steady state, spleen resident cDCs comprise CD8+ andCD8DCs that, as described for their pre-LN counterparts, differentiate from a common nonmonocytic
precursor and remain in an immature state in the absence of activating stimuli. During infection, inflammatory monocytes recruited to the splenic marginal zone
differentiate locally into spleen mo-DCs, and pre-existing resident cDCs are replaced by de novo-formed inflammatory CD8+ and CD8 DCs, derived from an
undefined precursor.particularly during bacterial infections (reviewed by Villadangos
and Schnorrer, 2007). This concept has been further supported
by a recent report proposing that the preferential ability of
CD8+ and CD8 DCs to prime CD8+ and CD4+ T cells, respec-
tively, correlates with the differential capacity of these DC sub-
sets to process and present antigens in association with MHC
class I and MHC class II molecules, respectively (Dudziak
et al., 2007). In addition, primarily on the basis of in vitro or com-
bined in vivo-in vitro assays, CD8+ and CD8 DCs were thought
to induce T helper (Th) 1- and Th2-polarized responses, respec-
tively (Maldonado-Lopez et al., 2001; Pulendran et al., 1999).
Table 1. Phenotype of Nonmucosal Conventional DCs
CD8+
DCsa
CD8
DCsa LCsa
Dermal
DCsa
Dermal
mo-DCsb
LN
mo-DCsb
CD11c +++ +++ ++ ++ ++ ++
CD11b + +++ +++ ++ ++ +++
Ly-6C   ND ++ ++ +++
CD8a +++  ++ ++ ++ 
SIRPa + +++ ++ ++ ND ND
MHC II ++ ++ +++ +++ +++ ++
DEC-205 +++  +++ ++ ++ 
DCIR2  +++   ND ND
Langerin ++  +++ /+++c ND ND
CD103 ++   ++ ND ND
‘‘,’’ ‘‘+,’’ ‘‘++,’’ and ‘‘+++’’ correspond to null, low, intermediate, and
high relative expression of the indicated marker, respectively, for the dif-
ferent DC subsets. ND, not determined.
a Phenotype in steady state for spleen and per-LN CD8+ and CD8 DCs
and for LCs and dermal DCs after migration into the per-LNs.
b Phenotype of mo-DCs generated in the dermis and per-LNs.
c Dermal DCs can be subdivided into Langerin+ and Langerin subsets.346 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.However, recent studies involving the analysis of in vivo immune
responses during infection have challenged these concepts by
demonstrating that CD8+ DCs are also involved in the induction
CD4+ and CD8+ T cell responses, not only during viral infections,
but also during bacterial and parasitic infections (Belz et al.,
2005; Maroof and Kaye, 2008; Yarovinsky et al., 2006). In addi-
tion, under certain experimental conditions, CD8 DCs can pro-
duce interleukin-12 (IL-12) (Edwards et al., 2003; Fallarino et al.,
2002; Fujii et al., 2003; Maldonado-Lopez et al., 2001) and could
therefore be involved in the induction of Th1 cell responses
against pathogens.
Although specific functions related to defense mechanisms
against viruses, bacteria, and parasites have been attributed to
different subsets of cDCs on the basis of recent advances in
DC-mediated immunity against infection, there still are contro-
versial points to be clarified. It is important to bear in mind that
current available information on the functional specialization of
DC subsets relies on studies that explored DC-mediated im-
mune responses against a limited number of pathogens and
that were performed with diverse experimental strategies. In ad-
dition, even though some precise functions have been assigned
to individual DC subsets on the basis of the expression of C-type
lectin antigen receptors (Carter et al., 2006; Dudziak et al., 2007;
Sancho et al., 2008), TLR activation receptors (Yarovinsky et al.,
2005), and chemokine receptors (Aliberti et al., 2000), a complete
definition of specific expression profiles for these receptors and
antigen-processing machinery should be performed to accu-
rately delineate the role of each DC subset in defense against
infection.
Roles of CD8+ DCs and Dermal DCs in Immune
Responses against Pathogens
In vivo studies that usedmouse experimental models of infection
by cytolytic and noncytolytic viruses (Allan et al., 2003; Allan
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Mount et al., 2008; Smith et al., 2003; Wilson et al., 2006), bacte-
ria (Belz et al., 2005; Yrlid and Wick, 2002), and parasites (Spo-
naas et al., 2006; Yarovinsky et al., 2006) strongly support the
concept that under physiological conditions, CD8+ DCs fulfill
a crucial role in the induction of protective Th1 cell responses
against intracellular pathogens. Consistent with this concept,
CD8+ DCs have been shown to be extremely efficient in produc-
ing IL-12 in vivo after microbial stimulation (Maldonado-Lopez
et al., 2001; Pulendran et al., 1999) and during in vivo infection
(Dalod et al., 2002; Maroof and Kaye, 2008; Reis e Sousa
et al., 1997; Yrlid and Wick, 2002). Interestingly, CD8+ DCs
have also been recently demonstrated to induce Th1 cell re-
sponses in vivo by an IL-12-independent, CD70-dependent
mechanism (Soares et al., 2007).
CD8+ DCs can activate CD4+ and CD8+ T cell responses after
internalization of pathogens or pathogen-derived antigens in
per-LNs or the spleen, either by direct presentation to CD4+ or
CD8+ T cells or by crosspresentation to CD8+ T cells (Allan
et al., 2003; Allan et al., 2006; Belz et al., 2004a; Belz et al.,
2005; Dalod et al., 2002; Mount et al., 2008; Smith et al., 2003;
Sponaas et al., 2006; Wilson et al., 2006: Yarovinsky et al.,
2006; Yrlid and Wick, 2002). Interestingly, recent data have led
to the concept that during cutaneous infections, skin migrating
dermal DCs and per-LN resident CD8+ DCs cooperate for the in-
duction of immune responses (Allan et al., 2003; Allan et al.,
2006; Belz et al., 2004b). During viral infections, per-LN CD8+
DCs have been demonstrated to activate CD8+ T cells by cross-
presentation of viral antigens transferred to CD8+ DCs by dermal
DCs that have uptaken those pathogens in the dermis and mi-
grated to the per-LNs; these dermal DCs were responsible for
the induction, within the per-LNs, of virus-specific CD4+ T cells
responses (Allan et al., 2006; Mount et al., 2008). In this regard,
several reports support the idea that dermal DCs play an essen-
tial role in the induction of CD4+ T cell responses against patho-
gens (Leon et al., 2007; Mount et al., 2008; Shklovskaya et al.,
2008). Correspondingly, dermal DCs express different C-type
lectin receptors, such as DEC-205, Langerin, and dectin-1, al-
lowing them to internalize exogenous antigens efficiently (Carter
et al., 2006; Ginhoux et al., 2007; Shklovskaya et al., 2008). A role
for dermal DCs in the crosspriming of CD8+ T cells during infec-
tion cannot be excluded, and such a role is supported by dermal
DCs’ expression of the C-type lectin DEC-205 (Shklovskaya
et al., 2008) and data on the crosspriming capacity of dermal
mo-DCs (Le Borgne et al., 2006).
CD8+ DCs are highly efficient in processing and presenting an-
tigens through the MHC class I pathway, either by direct presen-
tation or crosspresentation (den Haan et al., 2000; Dudziak et al.,
2007; Schnorrer et al., 2006), and CD8+ DCs represent the main
DC subset responsible for the induction of CD8+ T cell responses
against pathogens in vivo, particularly during viral infections (Al-
lan et al., 2003; Allan et al., 2006; Belz et al., 2004a; Belz et al.,
2005; Mount et al., 2008; Smith et al., 2003; Wilson et al.,
2006). The high crosspriming efficiency of CD8+ DCs has been
correlated with their ability to internalize dying cell-associated
antigens (Iyoda et al., 2002; Schulz and Reis e Sousa, 2002)
and with the expression of C-type lectin antigen receptors,
such as DEC-205 (Dudziak et al., 2007), CD36 (Tagliani et al.,
2008), and the recently described DC, NK lectin group recep-tor-1 (DNGR-1; Sancho et al., 2008), that target antigens to the
crosspriming processing pathway. Consistent with this notion,
analysis of gene-expression profiles suggest that CD8+ DCs, in
contrast to CD8+ DCs, are endowed with the antigen-processing
machinery required for crosspresentation (Dudziak et al., 2007).
A crucial role for CD8+ DCs in the induction of Th1 cell re-
sponses has also been demonstrated after infection by the en-
teroinvasive parasite Toxoplama gondii (Reis e Sousa et al.,
1997). Interestingly, IL-12 production by CD8+ DCs was trig-
gered after recognition of Toxoplasma-derived profilin by
TLR11, expressed by CD8+ DCs (Yarovinsky et al., 2005).
Splenic CD8+ DCs efficiently uptake Listeria monocytogenes
and appear to be essential for bacterial entry into the spleen
and subsequent initiation of defense mechanisms against this
microorganism (Neuenhahn et al., 2006). Finally, an immunoreg-
ulatory function leading to the suppression of T cell responses
and the control of excessive inflammatory reactions has been
proposed for CD8+ DCs; this function depends on a mechanism
mediated by the tryptophan metabolism pathway and initiated
by the induction of the enzyme indoleamine 2,3-dioxygenase
(IDO) (Fallarino et al., 2004). Interestingly, recent data support
a role for regulatory T cells in the induction of IDO in CD8+ DCs
by a reverse signaling mechanism that triggers the noncanonical
activation of the transcription factor NF-kB in CD8+ DCs (re-
viewed by Puccetti and Grohmann, 2007). However, a direct
implication of IDO-mediated negative regulation by CD8+ DCs
during in vivo immune responses against pathogens remains
to be demonstrated.
Role of CD8 DCs in Immune Responses against
Pathogens
In contrast to CD8+ DCs, CD8 DCs are very effective in captur-
ing pathogens and pathogen-derived antigens by phagocytosis
and endocytosis and presenting them to CD4+ T cells through
the MHC class II pathway (reviewed by Villadangos and Schnor-
rer, 2007). In this regard, CD8DCs efficiently induce CD4+ T cell
responses after antigen targeting via C-type lectin receptors,
such as dectin-1 and DCIR-2 (Carter et al., 2006; Dudziak
et al., 2007). However, CD8DCs have neither the capacity to in-
ternalize apoptotic cells nor to crosspresent antigens to CD8+
T cells (den Haan et al., 2000; Iyoda et al., 2002; Schulz and
Reis e Sousa, 2002). CD8 DCs express the C-type lectin recep-
tor DCIR2, recognized by the mAb 33D1, that has been pro-
posed to target antigens to the endocytic route involved in anti-
gen presentation to CD4+ T cells in the context of MHC class II
molecules. This pathway contrasts with the one involving DEC-
205 that directs antigens to the processing pathway leading to
antigen crosspresentation in the context of MHC class I mole-
cules (Dudziak et al., 2007). Thus, it appears that genes related
to the MHC class I processing and crosspresentation machinery
were preferentially activated in CD8+DCs, whereas those related
to the MHC class II processing machinery were preferentially ac-
tivated in CD8 DCs. The inefficiency of CD8 DCs at crosspre-
senting antigens would therefore be due to the lack of the cross-
presentation machinery and the lack of expression of C-type
lectin receptors, such as DEC-205 or DNGR-1, that target anti-
gens to the crosspresentation pathway.
As mentioned above, data on the induction of polarized Th1
and Th2 cell responses by CD8+ and CD8 DCs against solubleImmunity 29, September 19, 2008 ª2008 Elsevier Inc. 347
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12 producers and were mainly involved in the induction of Th2
cell responses (Maldonado-Lopez et al., 2001; Pulendran et al.,
1999). In line with this proposal, in several experimental models
of infection by viruses, bacteria, and parasites, CD8+ DCs, but
not CD8 DCs, were shown to be responsible for IL-12 produc-
tion and induction of Th1 cell responses (Dalod et al., 2002; Mar-
oof and Kaye, 2008; Reis e Sousa et al., 1997; Yrlid and Wick,
2002). In addition, CD8 DCs have been reported to activate
Th2-polarized T cell responses in vivo during infection from
Plasmodium chabaudi malaria parasites (Sponaas et al., 2006).
However, under certain experimental conditions, CD8 DCs
can produce IL-12. Thus, IL-12 production by CD8 DCs was
demonstrated in response to TLR-7 ligands (Edwards et al.,
2003), a-galactosylceramide (Fujii et al., 2003), and LPS in the
presence of anti-IL-10 (Fallarino et al., 2002; Maldonado-Lopez
et al., 2001). Interestingly, splenic CD8 DCs have been demon-
strated to induce CD4+ T cell responses during influenza virus in-
fection (Mount et al., 2008) and to induce Th1 cell-biased OVA-
specific T cell responses after LPS stimulation by a mechanism
that relies on Delta-4 Notch-ligand signaling and is independent
of IL-12 production (Skokos and Nussenzweig, 2007).
These data suggest that CD8 DCs could participate in either
Th1 or Th2 cell responses depending on different factors, such
as the activating stimulus and the internalization, processing,
and presentation of pathogen-derived antigens. Unfortunately,
only a limited number of reports analyzing the role of CD8 DCs
in immunity against pathogens have been published, and conse-
quently, additional experiments should be performed to improve
our understanding of the role played by CD8 DCs in immunity.
CD8 DCs have also been proposed to have a microbicidal
function through the production TNF-a and iNOS (Serbina
et al., 2003) and to participate in the regulation of Ig production
by B cells (Balazs et al., 2002). However, on the basis of recent
information on inflammatory de novo-formed DCs, it appears
that these functions could have been incorrectly attributed to
CD8 DCs and could be fulfilled by mo-DCs, as discussed in
the next section.
CD8 DCs express the inhibitory receptor SIRPa (Lahoud
et al., 2006), which appears to negatively control LC migration
(Fukunaga et al., 2004) and has been demonstrated to negatively
control IL-12 production after interaction with T cells expressing
SIPRa counter-receptor CD47 in human DCs (Latour et al.,
2001). This receptor has a crucial role in CD8 DC development
because this DC subset is severely reduced in CD47-deficient
mice (Hagnerud et al., 2006).
Role of Inflammatory mo-DCs in Immune Responses
against Pathogens
mo-DCs differentiated in the skin, per-LNs, and spleen during in-
fectious processes can play an important role in the induction
and regulation of immune responses against pathogens (re-
viewed in Leon and Ardavin, 2008b). Although only a few reports
have specifically addressed the role of mo-DCs in innate and
adaptive immunity, these studies have demonstrated that mo-
DCs can be essential for the induction of effective defensemech-
anisms against infection. This process applies particularly to
nonacute infectious and inflammatory processes that involve
the replacement of pre-existing DC subsets by de novo-formed348 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.inflammatory DCs. It is especially important to take into consid-
eration that, as discussed above, some relevant functions that
have been assigned to dermal DCs could be actually fulfilled
by dermal mo-DCs. These functions could include the capture
and transport of antigens to per-LN CD8+ DC for crosspresenta-
tion, the induction of CD4+ T cell responses by direct priming,
and, conceivably, CD8+ T cell crosspriming. This concept is sup-
ported first by the fact that within the per-LNs, both DC subsets
have a similar, if not identical, phenotype, and second by the ki-
netics of dermal DCmigration and de novo dermal mo-DC differ-
entiation, which suggests that dermal DCs are rapidly replaced
by dermal mo-DCs after the onset of an infectious process.
In line with these considerations, during Leishmania major in-
fection, monocytes were recruited to the dermis, draining per-
LNs, and spleen and differentiated into dermal mo-DCs, LN
mo-DCs, and spleen mo-DCs, respectively (Leon et al., 2007).
Dermal mo-DCs acquired a mature phenotype after migration
to the per-LNs and were demonstrated to be responsible for
the induction of protective CD4+ Th1 cell responses against
the parasite. Consistent with this finding, during subcutaneous
Salmonella infection, CD4+ T cells were activated byDCs derived
from monocytes recruited to the dermis by a CCR6-dependent
mechanism (Ravindran et al., 2007). In contrast, LN mo-DCs dif-
ferentiated from monocytes recruited to the per-LNs during
Leishmania infection (Leon et al., 2007) exhibited an immature
phenotype and did not appear to contribute substantially to
T cell immunity against Leishmania. The function of LN mo-
DCs and spleen mo-DCs during Leishmania infection remains
to be defined, although it can be speculated that they could par-
ticipate in innate-immunity defense mechanisms, on the basis of
the role of spleenmo-DCs during Listeria infection (Serbina et al.,
2003). Splenic DCs, formed de novo during infection by Listeria
monocytogenes from monocytes recruited to the spleen by
a CCR2-dependent mechanism, displayed a highly effective mi-
crobicidal potential on the basis of their capacity to produce
TNF-a and nitric oxide; these mo-DCs have been named Tip
DCs (TNF-a- and iNOS-producing DCs). Tip DCs, which dis-
played a similar phenotype to LN and spleen mo-DCs formed
in Leishmania-infected mice (Leon et al., 2007), were essential
for defense against Listeria infection, as demonstrated in
CCR2-deficient mice that could not control bacterial replication
(Serbina et al., 2003). Interestingly, DCs newly formed in the
marginal zone of the spleen during infection by Streptococcus
pneumoniae were also claimed to correspond phenotypically
to Tip DCs (Balazs et al., 2002). These DCs were involved in
the induction of T cell-independent B cell responses and in the
differentiation of IgM-producing plasma cells by a mechanism
relying on the production, by DCs, of the recently described
TNF superfamily molecules B lymphocyte stimulator (BlyS) and
a proliferation-inducing ligand (APRIL).
These data suggest that whereas mature dermal mo-DCs dis-
play an essential role in the induction of pathogen-specific T cell
responses, immature LN and spleen mo-DCs would be involved
in pathogen killing and participate in the regulation of Ig produc-
tion by B cells.
Conclusions and Future Research Directions
Recent research on the specific functions fulfilled by different
DC subsets during in vivo immune responses have challenged
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Reviewcertain paradigms of DC immunobiology, revealed unexpected
functions for some DC subsets, and contributed to the descrip-
tion of new DC subsets. Whereas the participation of LCs in
immunity against pathogens under physiological conditions rep-
resents a yet-unsolved controversy, dermal DCs have recently
arisen as critical effectors of immune responses during cutane-
ous infections by virtue of their capacity to efficiently capture,
transport, and present pathogen-derived antigens to per-LN
CD4+ T cells. Moreover, they enable the crosspriming of CD8+
T cells by resident CD8+ DCs by providing the latter with patho-
gen-derived antigens. Importantly, the finding that mo-DCs
formed de novo during infection in antigen-capture areas and
lymphoid organs can be responsible for the induction of protec-
tive immune responses against pathogens has led to the devel-
Figure 3. Integrated Model of the Specific Functions Ascribed to the
Different Per-LN cDC Subsets during Infectious Processes
Migratory monocyte-derived LCs, dermal DCs, and dermal mo-DCs capture
pathogens or pathogen-derived antigens in the skin, transport them to the
pre-LNs, and can transfer them to resident CD8+ DCs. Both dermal DCs and
dermal mo-DCs can also efficiently activate CD4+ T cells within the per-LNs.
CD8+ DCs are highly efficient in activating CD8+ T cells by direct presentation
or crosspresentation, whereas resident CD8 DCs would preferentially acti-
vate CD4+ T cells. Finally, LN mo-DCs that display an immature phenotype
can have a microbicidal function by producing TNFa and nitric oxide, and
they participate in Ig production by B cells through a mechanism dependent
on the production of APRIL and BlyS by mo-DCs.opment of a new active area of research in DC immunobiology,
one that will provide important insights regarding the induction
and control of immune responses during inflammation and infec-
tion (see Belkaid and Oldenhove, 2008 [in this issue]). An inte-
grated view of the specific functions ascribed to migratory and
resident cDCs during infection is shown in Figure 3.
There are numerous controversial and unresolved issues sur-
rounding DC-mediated immune responses against pathogens.
Therefore, definitive conclusions cannot yet be drawn on the
complete set of functions fulfilled by each cDC subset, functions
that appear to be defined by multiple factors, including the con-
trol of their differentiation under steady state and inflammation,
their location within lymphoid organs, and the expression of spe-
cific antigen-capture receptors, TLR and other activating recep-
tors, cytokine and chemokine receptors, and components of the
antigen-processing and presentation machinery. Therefore, an
in-depth analysis of all these aspects of the immunobiology of
the different DC subsets would contribute substantially to the
defining of the functional specialization of the different cDC sub-
sets during immune responses against pathogens.
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